13F-HR filed by Velan Capital Investment Management LP
Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-13, with 46 holding rows worth $172,378,588.
- Accession
- 0001848809-26-000001
- Filer
- CIK 1848809
- Filed
- 2026-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 48 entries on the cover page, a total value of $172,378,588 stated on the cover page (in dollars after the unit check, H1), rows summing to $172,378,588 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 100,781 | $29,704,192 | dollars as filed | |
| CIDARA THERAPEUTICS INC | 171757206 | COM NEW | 108,404 | $23,945,360 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 2,834,652 | $15,108,695 | dollars as filed | |
| HERON THERAPEUTICS INC | 427746102 | COM | 8,753,290 | $11,379,277 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 522,305 | $9,174,288 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 67,000 | $9,035,285 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 506,754 | $8,675,628 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 151,000 | $5,479,790 | dollars as filed | |
| LANTHEUS HLDGS INC | 516544103 | COM | 74,687 | $4,970,420 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871202 | COM NEW | 2,668,395 | $4,883,163 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 263,642 | $4,787,739 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,210,000 | $4,477,000 | dollars as filed | |
| VERRICA PHARMACEUTICALS INC | 92511W207 | COM SHS | 471,559 | $3,918,655 | dollars as filed | |
| INSPIREMD INC | 45779A846 | COM | 2,143,698 | $3,815,782 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E208 | COM NEW | 108,000 | $3,657,960 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367201 | COMMON STOCK | 312,000 | $3,609,840 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 70,000 | $2,828,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 130,000 | $2,731,300 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 86,500 | $2,691,880 | dollars as filed | |
| EUPRAXIA PHARMACEUTICALS INC | 29842P105 | COM 298736 AL 3 EURONET WORLDWIDE INC NOTE 0.750% 3/1 | 352,000 | $2,657,600 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 205,000 | $2,566,600 | dollars as filed | |
| PROFOUND MED CORP | 74319B502 | COM NEW | 285,710 | $2,248,538 | dollars as filed | |
| KAZIA THERAPEUTICS LTD | 48669G303 | SPONSORED ADS | 300,000 | $2,067,000 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 750,000 | $1,770,000 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 83,333 | $1,015,829 | dollars as filed | |
| EDESA BIOTECH INC | 27966L306 | COM NEW | 687,500 | $976,250 | dollars as filed | |
| TREVI THERAPEUTICS INC | 89532M901 | COM | 38,500 | $482,020 | dollars as filed | call |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 6,500 | $431,535 | dollars as filed | |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 40,000 | $361,200 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 80,000 | $340,800 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 3,700 | $323,158 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 16,000 | $303,520 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 160,000 | $260,800 | dollars as filed | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 70,000 | $217,000 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 10,000 | $214,800 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 20,000 | $187,600 | dollars as filed | |
| IMMIX BIOPHARMA INC | 45258H106 | COMMON STOCK | 35,000 | $183,050 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 100,000 | $147,000 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 15,000 | $145,800 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 33,000 | $125,730 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 170,000 | $108,834 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 13,000 | $105,820 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 45,000 | $90,900 | dollars as filed | |
| PRECISION BIOSCIENCES INC | 74019P207 | COM NEW | 20,000 | $83,200 | dollars as filed | |
| PYXIS ONCOLOGY INC COMMON STOCK | 747324101 | Stock | 40,000 | $46,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 35,000 | $43,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001848809-26-000001 | this filing | 2026-02-13 | acceptance time not in the bulk data set |